Company
brbiotech
Burning Rock Dx (NASDAQ: BNR) is a global diagnostics company focusing on applying next-generation sequencing (NGS) technology in precision oncology.
Also known as Burning Rock Biotech Limited, Burning Rock Dx
- Status
- Operatingas of 2026-09-17
- Business model
- B2B
- Headquarters
- Guangzhou, Guangdong, China
- Customers
- scientists, clinicians, medical providers, and pharmaceutical companies
- Legal name
- Burning Rock Biotech Limited
- brbiotech.com (opens in a new tab)
- LinkedIn (opens in a new tab)
- X (opens in a new tab)
- Press page (opens in a new tab)
- Careers (opens in a new tab)
Claim, correct or request removal
Record updated 17 September 2026
About
Burning Rock Dx (NASDAQ: BNR) is a global diagnostics company focusing on applying next-generation sequencing (NGS) technology in precision oncology. Guided by the mission of “Guard Life via Science,” Burning Rock offers solutions covering the entire precision oncology development cycle through an internally developed NGS-based assay portfolio for both tissue and blood samples, along with a robust in-house database to help facilitate clinical trial studies and research.
Products
- Other
- OncoCompass Plus (Liquid biopsy)
- Other
- OncoScreen Focus
- Other
- OncoScreen Plus (Tissue)
Loading relationship preview